Elevated prothrombin time/international normalized ratio associated with concurrent administration of regorafenib and warfarin in a patient with advanced colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-0294
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Elevated prothrombin time/international normalized ratio associated with concurrent administration of regorafenib and warfarin in a patient with advanced colorectal cancer ; volume:2 ; number:1 ; day:8 ; month:7 ; year:2016 ; pages:1-5 ; date:12.2016
Journal of pharmaceutical health care and sciences ; 2, Heft 1 (8.7.2016), 1-5, 12.2016
- Creator
-
Kitade, Hironori
- Contributor
-
Hiromasa-Yamasaki, Azusa
Hokkoku, Kengo
Mori, Mitsue
Watanabe, Michio
Nakai, Masuo
Yano, Seiji
SpringerLink (Online service)
- DOI
-
10.1186/s40780-016-0050-y
- URN
-
urn:nbn:de:1111-2016071121112
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kitade, Hironori
- Hiromasa-Yamasaki, Azusa
- Hokkoku, Kengo
- Mori, Mitsue
- Watanabe, Michio
- Nakai, Masuo
- Yano, Seiji
- SpringerLink (Online service)
Other Objects (12)
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report
In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia
Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement
Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients
Automatically annotating documents with normalized gene lists
The Conversion of Bovine Abnormal Prothrombin into Prothrombin
A case of a warfarinized renal cancer patient monitored for prothrombin time-international normalized ratio during methadone introduction
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report
In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia
Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement
Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients
Automatically annotating documents with normalized gene lists
The Conversion of Bovine Abnormal Prothrombin into Prothrombin
A case of a warfarinized renal cancer patient monitored for prothrombin time-international normalized ratio during methadone introduction
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report
In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia
Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement
Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients
Automatically annotating documents with normalized gene lists
The Conversion of Bovine Abnormal Prothrombin into Prothrombin